Cellular immunotherapy for cancer: current concepts and clinical perspectives Monitoring immune responses and clinical trials: part II.
Spicer
J
J
Department of Urology, St George's Hospital Medical School, London, UK.
Quatan
N
N
Plunkett
T
T
Pandha
H
H
D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy; D015179:Colorectal Neoplasms / Q000276:immunology / Q000628:therapy; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D016233:Immunotherapy, Active; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008223:Lymphoma / Q000276:immunology / Q000628:therapy; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000628:therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000276:immunology / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000628:therapy